WASHINGTON — Federal Medicaid officials are working unusually closely with states to avoid enrollment glitches and remove excuses states might have for not
Tag - CMS
Medicare is willing to reevaluate its coverage of Alzheimer’s drugs in light of a new therapy, called lecanemab, that has shown potentially more promising
AUSTIN, Texas – Chiquita Brooks-LaSure, the head of Medicare, said on Thursday that the agency expects to keep covering drugs the Food and Drug Administration
